These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16799155)

  • 41. Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.
    Foulds CE; Nelson ML; Blaszczak AG; Graves BJ
    Mol Cell Biol; 2004 Dec; 24(24):10954-64. PubMed ID: 15572696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry.
    Lee T; Hoofnagle AN; Kabuyama Y; Stroud J; Min X; Goldsmith EJ; Chen L; Resing KA; Ahn NG
    Mol Cell; 2004 Apr; 14(1):43-55. PubMed ID: 15068802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1.
    Monje P; Hernández-Losa J; Lyons RJ; Castellone MD; Gutkind JS
    J Biol Chem; 2005 Oct; 280(42):35081-4. PubMed ID: 16123044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The nuclear import of protein kinase D3 requires its catalytic activity.
    Rey O; Papazyan R; Waldron RT; Young SH; Lippincott-Schwartz J; Jacamo R; Rozengurt E
    J Biol Chem; 2006 Feb; 281(8):5149-57. PubMed ID: 16380377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity.
    Medunjanin S; Hermani A; De Servi B; Grisouard J; Rincke G; Mayer D
    J Biol Chem; 2005 Sep; 280(38):33006-14. PubMed ID: 16076840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ERF and ETV3L are retinoic acid-inducible repressors required for primary neurogenesis.
    Janesick A; Abbey R; Chung C; Liu S; Taketani M; Blumberg B
    Development; 2013 Aug; 140(15):3095-106. PubMed ID: 23824578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired repressor activity and biological functions of PU.1 in MEL cells induced by mutations in the acetylation motifs within the ETS domain.
    Kihara-Negishi F; Suzuki M; Yamada T; Sakurai T; Oikawa T
    Biochem Biophys Res Commun; 2005 Sep; 335(2):477-84. PubMed ID: 16098914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Cyclin Dependent Kinase 10 and Transcription Factor 2 during Human Corneal Epithelial Wound Healing in vitro model.
    Zehra M; Mushtaq S; Ghulam Musharraf S; Ghani R; Ahmed N
    Sci Rep; 2019 Aug; 9(1):11802. PubMed ID: 31413335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subcellular localization determines the protective effects of activated ERK2 against distinct apoptogenic stimuli in myeloid leukemia cells.
    Ajenjo N; Cañón E; Sánchez-Pérez I; Matallanas D; León J; Perona R; Crespo P
    J Biol Chem; 2004 Jul; 279(31):32813-23. PubMed ID: 15173174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphorylation of Krüppel-like factor 3 (KLF3/BKLF) and C-terminal binding protein 2 (CtBP2) by homeodomain-interacting protein kinase 2 (HIPK2) modulates KLF3 DNA binding and activity.
    Dewi V; Kwok A; Lee S; Lee MM; Tan YM; Nicholas HR; Isono K; Wienert B; Mak KS; Knights AJ; Quinlan KG; Cordwell SJ; Funnell AP; Pearson RC; Crossley M
    J Biol Chem; 2015 Mar; 290(13):8591-605. PubMed ID: 25659434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of PI3K induces Rac activation and membrane ruffling in proto-Dbl expressing cells.
    Vanni C; Visco V; Mancini P; Parodi A; Ottaviano C; Ognibene M; Manazza AD; Retta SF; Varesio L; Torrisi MR; Eva A
    Cell Cycle; 2006 Nov; 5(22):2657-65. PubMed ID: 17172840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs.
    Seta K; Nanamori M; Modrall JG; Neubig RR; Sadoshima J
    J Biol Chem; 2002 Mar; 277(11):9268-77. PubMed ID: 11777928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases-Current State of the Art.
    Smorodinsky-Atias K; Soudah N; Engelberg D
    Cells; 2020 Jan; 9(1):. PubMed ID: 31935908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Active ERK2 is sufficient to mediate growth arrest and differentiation signaling.
    Wu PK; Hong SK; Yoon SH; Park JI
    FEBS J; 2015 Mar; 282(6):1017-30. PubMed ID: 25639353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
    Chan YJ; Chiou CJ; Huang Q; Hayward GS
    J Virol; 1996 Dec; 70(12):8590-605. PubMed ID: 8970984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
    Zhang J; Zhou B; Zheng CF; Zhang ZY
    J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation.
    She QB; Chen N; Dong Z
    J Biol Chem; 2000 Jul; 275(27):20444-9. PubMed ID: 10781582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.
    Bax B; Carter PS; Lewis C; Guy AR; Bridges A; Tanner R; Pettman G; Mannix C; Culbert AA; Brown MJ; Smith DG; Reith AD
    Structure; 2001 Dec; 9(12):1143-52. PubMed ID: 11738041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New insights for Ets2 function in trophoblast using lentivirus-mediated gene knockdown in trophoblast stem cells.
    Odiatis C; Georgiades P
    Placenta; 2010 Jul; 31(7):630-40. PubMed ID: 20569982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases.
    Westwick JK; Cox AD; Der CJ; Cobb MH; Hibi M; Karin M; Brenner DA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6030-4. PubMed ID: 8016110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.